Last reviewed · How we verify
Insulin detemir and pre-meal insulin aspart. — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Insulin detemir and pre-meal insulin aspart. (Insulin detemir and pre-meal insulin aspart.) — University of Florida.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Insulin detemir and pre-meal insulin aspart. TARGET | Insulin detemir and pre-meal insulin aspart. | University of Florida | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Insulin detemir and pre-meal insulin aspart. CI watch — RSS
- Insulin detemir and pre-meal insulin aspart. CI watch — Atom
- Insulin detemir and pre-meal insulin aspart. CI watch — JSON
- Insulin detemir and pre-meal insulin aspart. alone — RSS
Cite this brief
Drug Landscape (2026). Insulin detemir and pre-meal insulin aspart. — Competitive Intelligence Brief. https://druglandscape.com/ci/insulin-detemir-and-pre-meal-insulin-aspart. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab